Main attributes Anastrozol (Arimidex)
Manufacturer:
PharmaxLab®
Brand name:
Anastrox
Commercial name:
Arimidex, Anastrozole
Form of release:
Oral tablets
Dosage:
1mg per tablet
Amount in a package:
60 tab
Drug class:
Aromatase inhibitor
Mechanism of Action:
Inhibits the enzyme aromatase, reducing estrogen production in the body
Indications:
Treatment of hormone receptor-positive breast cancer in postmenopausal women, and in postmenopausal women at high risk of breast cancer for risk reduction
Active ingredient:
Anastrozole
CAS Name:
2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-yl)phenyl]-2-methylpropanenitrile
CAS Number:
120511-73-1
Molecular Formula:
C17H19N5
Method of use:
Oral administration
Best time to take:
Typically taken once daily
Typical Dosage:
1mg per day for breast cancer treatment
Anabolic activity:
Not applicable (not anabolic steroid)
Androgen activity:
Not applicable (not anabolic steroid)
Aromatisation (conversion to estrogens):
Does not convert to estrogen
Side Effects:
Can include hot flashes, joint pain, nausea, and increased risk of osteoporosis
Half-life
Approximately 50 hours
Toxicity:
Generally well-tolerated, but can cause side effects such as hot flashes, joint pain, and increased risk of osteoporosis
Detection time:
Not applicable (used in medical therapy)
Contraindications:
Hypersensitivity to anastrozole, pregnancy, breastfeeding, severe liver disease
Interaction with other steroids:
Not applicable (not anabolic steroid)
Precautions:
Regular monitoring for bone density changes, liver function tests, and lipid levels is recommended during therapy
Overdose:
Limited information available, but excessive doses may increase side effects
Age category:
Typically used by adults, not recommended for use in adolescents or children
Legal Status:
Prescription medication, regulated as a prescription drug
Storage conditions:
Store at room temperature away from moisture and heat